1 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18026034 | NOVEL COPI/ARF1-LIPOLYSIS PATHWAY INHIBITOR AND COMPOUND FOR ERADICATING CANCER STEM CELLS AND INDUCING DAMP-MEDIATED ANTI-TUMOR IMMUNE RESPONSE | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Mar 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial